| 000 | 01656 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514020926.0 | ||
| 264 | 0 | _c20020122 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm0102203 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorthwick, Alan D | |
| 245 | 0 | 0 |
_aDesign and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJan 2002 |
||
| 300 |
_a1-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xchemical synthesis |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aCytomegalovirus _xchemistry |
| 650 | 0 | 4 |
_aLactams _xchemical synthesis |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aPyrroles _xchemical synthesis |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xchemistry |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aCrame, Andrew J | |
| 700 | 1 | _aErtl, Peter F | |
| 700 | 1 | _aExall, Anne M | |
| 700 | 1 | _aHaley, Terry M | |
| 700 | 1 | _aHart, Graham J | |
| 700 | 1 | _aMason, Andrew M | |
| 700 | 1 | _aPennell, Andrew M K | |
| 700 | 1 | _aSingh, Onkar M P | |
| 700 | 1 | _aWeingarten, Gordon G | |
| 700 | 1 | _aWoolven, James M | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 45 _gno. 1 _gp. 1-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm0102203 _zAvailable from publisher's website |
| 999 |
_c11666992 _d11666992 |
||